Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
6.41
-0.01 (-0.16%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $10.54 million as of September 18, 2025. Its market cap has decreased by -49.94% in one year.
Market Cap
10.54M
Enterprise Value
13.23M
1-Year Change
-49.94%
Ranking
Category
Stock Price
$6.41
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $10.54M, a decrease of -95.42%. That is a compound annual growth rate of -43.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 10.54M | -21.98% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
| May 1, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |